Affilin
Affilin is a class of proteins that are used in the field of biotechnology for various applications. They are derived from the ubiquitin protein and are characterized by their small size, high stability, and ability to bind to a wide range of targets.
History[edit | edit source]
The concept of Affilin was first introduced by the German biotech company Scil Proteins in the early 2000s. The company was interested in developing new types of binding proteins that could be used in therapeutic and diagnostic applications. They chose ubiquitin as the basis for their new proteins because of its small size and high stability.
Structure and Function[edit | edit source]
Affilin proteins are derived from ubiquitin, a small protein that is found in all eukaryotic cells. Ubiquitin has a highly stable structure that is resistant to changes in temperature, pH, and other environmental conditions. This makes it an ideal scaffold for the development of new binding proteins.
The structure of Affilin proteins is similar to that of ubiquitin, but with modifications that allow them to bind to a wide range of targets. These modifications include the addition of amino acid sequences that are designed to interact with specific target molecules.
Affilin proteins can be engineered to bind to a wide range of targets, including proteins, nucleic acids, and small molecules. This makes them useful for a variety of applications in biotechnology, including drug delivery, diagnostics, and therapeutics.
Applications[edit | edit source]
Affilin proteins have been used in a variety of applications in biotechnology. One of the most common uses is in drug delivery, where they can be used to target specific cells or tissues in the body. They can also be used in diagnostics, where they can be used to detect the presence of specific molecules or cells.
In addition to these applications, Affilin proteins are also being explored for use in therapeutics. For example, they can be engineered to bind to and inhibit the function of disease-causing proteins. This could potentially be used to treat a wide range of diseases, including cancer, autoimmune diseases, and infectious diseases.
See Also[edit | edit source]
 | This protein-related article is a stub. You can help WikiMD by expanding it. |
 | This biotechnology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
